Refractory Melanoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB08885 | Aflibercept | 1 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 1 | Recruiting | 1 |
DB12218 | Capivasertib | 1 | Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 / 2 | Completed | 1 |
DB09035 | Nivolumab | 1 / 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
DB11105 | Benzalkonium | 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB00482 | Celecoxib | 2 | Recruiting | 1 |
DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
DB05258 | Interferon alfa | 2 | Recruiting | 1 |
DB00105 | Interferon alfa-2b | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB12146 | Rigosertib | 2 | Recruiting | 1 |
DB16425 | Rintatolimod | 2 | Recruiting | 1 |
DB04960 | Tipifarnib | 2 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 2 | Completed | 1 |